The Facts

• "A monumental milestone" in the battle against malaria was set Monday with the rollout of the R21/Matrix-M vaccine in the West African nation of Cote d'Ivoire."A monumental milestone" in the battle against malaria was set Monday with the rollout of the "R21/Matrix-M" vaccine in the West African nation of the Ivory Coast.

• Co-developed by the University of Oxford and Serum Institute of India, the vaccine is set immunize around 6.6M children in 15 African nations over 2024-25.Co-developed by the University of Oxford and the Serum Institute of India, the vaccine is targeted to immunize around 6.6M children in 15 African nations from 2024-25.

• R21/Matrix-M, which costs less than $4 per dose, is the second such vaccine. RTS,S, launched earlier this, costs twice as much and faces manufacturing hurdles.The jab which costs less than $4 per dose, is the second such vaccine. "RTS,S," launched earlier this, costs twice as much and reportedly faces manufacturing hurdles.